The daily plenary sessions will be held in the La Nouvelle Orleans Ballroom at the Convention Center.
Saturday, October 20
10:30 AM – 12:15 PM
P1065 AAP Education Award
Recipient Lawrence Nazarian, MD, FAAP
The AAP Education Award recognizes a member of the Academy whose career reflects educational contributions that have had a broad and positive impact on the health and well-being of infants, children, adolescents and young adults.
P1066 AAP President's Address
Robert Block, MD, FAAP
Join AAP President Robert W. Block, MD, FAAP, as he discusses the importance of pediatricians...and the AAP...awakening and adapting to the demands of changing times. Dr Block also will provide an update on the Academy’s efforts to advance our Agenda for Children and reflect on his year as AAP President.
P1067 Keynote Address
Walt Handelsman, recipient of the Pulitzer Prize in Journalism, will discuss and illustrate the use of cartoons and videos to portray our current political landscape, including its impact on the lives of our nation’s children.
P1068 Ensuring Quality: What Can be Done at Your Practice
Robert Gillespie, MD, MHPE, FAAP
Pediatricians are in a key position to ensure quality health care for children, as well as improve the structure, process, and outcomes of the care that is delivered. This presentation will review and demonstrate the impact of quality improvement initiatives that can be undertaken at the practice and local level.
P1069 Drug Shortages
Stephen Spielberg, MD, PhD, FAAP
The pediatric drug shortage crisis is ongoing. Unavailability of drugs can lead to delays in treatment, less familiar medications being substituted for the more familiar drugs that are in short supply, rationing, or in some cases, death. This session will discuss determinants of the availability of medicines.
Sunday, October 21
10:30 AM – 12:10 PM
P2065 New Insights on Racial Disparities in Birth Outcomes
James Collins, Jr, MD, MPH, FAAP
This presentation will review the history and current status of racial disparities in infant outcomes. The many factors that contribute to this disparity will be identified, with an emerging perspective on why shortterm strategies to address these factors have had little impact, and where our efforts need to be directed in the future.
P2066 Transforming Communities to Improve School Readiness
Neal Halfon, MD, MPH, FAAP
By integrating health care, child care and early education, and family support systems, the Transforming Early Childhood Community Systems program is a research-based effort to build collective responsibility and action by community stakeholders to enhance early brain and child development and prepare children for success by the time they enter kindergarten. This developmentally sound community development initiative applies teacher assessment of children’s development, community asset mapping, and community organizing. This plenary session will provide you the opportunity to gain knowledge of this project and the use of collaborative innovation networks.
P2067 The Surgeon General’s Call to Action in Support of Breastfeeding
Laurence Grummer-Strawn, PhD
This session will provide an update on our national progress in achieving the breastfeeding objectives laid out in the 2011 Surgeon General’s Call to Action and Healthy People 2020 and identify how pediatric providers can advocate for change within their hospitals, practices, and communities
to improve breastfeeding initiation and continuation rates, as well as exclusive breastfeeding rates.
P2068 Preparing for ICD-10-CM
Jeffrey Linzer, Sr, MD, FACEP, FAAP
Faculty will provide an overview of ICD-10-CM and provide suggestions for efficient practice implementation of the new nomenclature. Highlights on ICD-11 “coming attractions” will also be addressed.
P2069 Intrauterine Determinants of Obesity
Emily Oken, MD
The obesity epidemic has spared no segment of the population, even infants and young children. This presentation will review the role of experiences in early life, even before birth, in contributing to risk for childhood obesity, and identify factors that may be targeted for prevention in pediatric practice.
Monday, October 22
10:30 AM – 12:30 PM
P3065 Molecularly Informed Therapy for Pediatric Disease
Bruce Korf, MD, FAAP
The ability to sequence the human genome and to identify the underlying genetic alterations in disease has allowed us to understand the underlying molecular mechanisms in many pediatric diseases. This has now resulted in the development of molecularly informed medical therapies for several types of cancer and the initiation of clinical trials for many previously untreatable conditions, including neurofibromatosis 1, fragile X syndrome, tuberous sclerosis, and Down syndrome.
P3066 Whole Genome Sequencing and the Future of Pediatrics
James Evans, MD
As technology improves and costs decrease, whole genome sequencing is moving from the research lab to patient use. This session will give busy pediatricians a framework for understanding the concept of whole genome sequencing and what it will mean for their patients. Specific examples of where this process has resulted in diagnosis and specific treatment and the types of patients who would be best helped with this type of testing when it is available will be detailed.
P3067 Life Trauma and PTSD in Children: What is a Pediatrician To Do?
Charles Zeanah, MD
Children who have experienced abuse/neglect, natural disasters, parental military deployment, and other events that disrupt their lives need to be monitored so that supportive care can be provided and therapeutic intervention be initiated when mental health issues such as post-traumatic stress disorder (PTSD) emerge. Knowing the warning signs and red flags for these issues and treatment options are critical in helping children through traumatic periods of their lives and helping them to move forward on a healthy developmental trajectory.
P3068 Overprescription of Acid-Suppressing Drugs in Infants and Children: A Risky Business
Eric Hassall, MD
This plenary will address the overuse of acid suppressant drugs for symptoms purported to be those of gastroesophageal (GE) reflux disease. Evidence showing the benefits of acidsuppressing drugs in GE reflux disease will be presented, as will evidence showing potential risks of these drugs. The issue of overprescription will focus primarily on the infant age group.
P3069 The Gut Microbiome in Health and Disease–You are Who you Live With!
Philip Sherman, MD
This session will describe the role of the gut microbiome in human health and disease. Factors affecting the composition of the gut microbiome, including the role of breastfeeding, diet, and use of antibiotics, will be highlighted. The future potential to manipulate the host’s gut microbiome to prevent or treat diseases will be addressed.
P3064 All’s Fair: Love, War and Politics
James Carville and Mary Matalin
(Special Guest Appearance Following Plenary in the Exhibit Hall 12:45pm–1:15pm)
One of America’s best-loved political couples—James Carville and Mary Matalin—give an enlightening and entertaining look at today’s most important political issues as well as a behind-the-scenes look at politics inside Washington and how today’s headlines are playing out around the country.
Tuesday, October 23
10:30 AM – 12:10 PM
P4055 Christopherson Lecture
The Christopherson Lecture will be presented by Mr Stephen Lewis, the co-founder and co-director of AIDS-Free World, an international advocacy organization that works to promote more urgent and more effective global responses to HIV/AIDS. Stephen Lewis’ work with the United Nations spanned more than two decades. He was the UN Secretary-General’s Special Envoy for HIV/AIDS in Africa from June 2001 until the end of 2006. From 1995 to 1999, Mr. Lewis was Deputy Executive Director of UNICEF at the organization’s global headquarters in New York. From 1984 through 1988, he was Canada’s Ambassador to the United Nations.
P4056 Autism: What We Know and What We Need To Know!
Susan Swedo, MD, FAAP
This plenary will summarize what we know and what we need to know about autism. It will describe the evidence for autism as a developmental brain disorder likely due to synaptic dysfunction. Faculty will describe the biologic and genetic evidence that supports this understanding as well as the heterogeneity that complicates our understanding of autism.
P4057 Return to Play: Neuromuscular Training (NMT)
Cynthia LaBella, MD, FAAP
A growing number of young athletes are presenting to pediatricians for management of sports-related injuries and guidance regarding safe return to play. This session will describe the key elements that guide return-to-play decisions for knee injury. Risk factors for knee injury will be highlighted and the evidence for NMT as an injury
prevention strategy will be summarized.
P4058 Speak Up for Children at the Ballot Box
Mark Del Monte, JD
On November 6, voters will decide hundreds of elections at the federal level and thousands more in state races. As advocates for children, pediatricians have a stake in the future direction of public policy at every level. AAP has launched a Get Out the Vote Campaign to encourage all pediatricians to vote. This session will highlight what pediatricians can do to assure children are not forgotten in ongoing political debates.
P4059 Neonatal HSV: New Insights Including Post-Treatment Prophylaxis
David Kimberlin, MD, FAAP
Provide an update of recent advances in the diagnosis and management of neonatal Herpes simplex virus infection and disease. This includes changes to the diagnostic approach in the 2012 Red Book, and long-term oral antiviral suppression following completion of intravenous acyclovir treatment. New management algorithms from the AAP will be emphasized.